COHERUS BIOSCIENCES INC (CHRS)
US19249H1032 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 259.77M | 102.89M | 63.50M | 417.20M | 541.20M | |||
| Marketable Securities | 0.00 | 14.86M | 128.10M | N/A | N/A | |||
| Receivables | 284.14M | 260.52M | 110.00M | 123.00M | 157.00M | |||
| Inventories | 61.98M | 62.60M | 38.80M | 37.60M | 44.20M | |||
| Other Current Assets | 21.58M | 34.76M | 40.80M | 24.50M | 25.00M | |||
| Total Current Assets | 627.48M | 475.63M | 381.20M | 602.30M | 767.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.19M | 11.03M | 14.40M | 16.00M | 20.10M | |||
| Goodwill | 0.00 | 943.00K | N/A | 900.00K | 900.00K | |||
| Intangibles | 57.10M | 70.73M | 5.90M | 2.60M | 2.60M | |||
| Other Non-Current Assets | 74.78M | 71.27M | 79.20M | 57.40M | 50.50M | |||
| Total Non-Current Assets | 136.07M | 153.97M | 99.60M | 77.00M | 74.10M | |||
| TOTAL ASSETS | 763.54M | 629.60M | 480.80M | 679.30M | 841.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 175.00M | 721.00K | 1.20M | 700.00K | 600.00K | |||
| Accrued Expenses | 294.24M | 292.53M | 126.00M | 148.40M | 129.20M | |||
| Accounts Payable | 38.29M | 35.22M | 11.50M | 16.20M | 15.20M | |||
| Other Current Liabilities | 30.77M | 3.30M | N/A | N/A | 700.00K | |||
| Total Current Liabilities | 538.30M | 331.77M | 138.70M | 165.30M | 145.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 299.67M | 473.72M | 472.50M | 408.80M | 404.90M | |||
| Deferred Taxes/Income | 1.10M | 1.10M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 6.31M | 16.44M | 7.10M | 7.50M | 10.10M | |||
| Total Non-Current Liabilities | 307.09M | 491.26M | 479.60M | 416.30M | 415.00M | |||
| TOTAL LIABILITIES | 845.39M | 823.03M | 618.30M | 581.60M | 560.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.48B | -1.58B | -1.34B | -1.05B | -762.80M | |||
| Additional Paid In Capital | 1.40B | 1.39B | 1.20B | 1.15B | 1.04B | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 11.00K | 11.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -272.00K | -248.00K | -200.00K | -300.00K | -300.00K | |||
| Shares Outstanding | 113.50M | 112.22M | 78.90M | 76.90M | 72.50M | |||
| Tangible Book Value per Share | -1.22 | -2.36 | -1.82 | 1.23 | 3.83 | |||
| Total Shareholders' Equity | -81.84M | -193.43M | -137.40M | 97.70M | 281.00M | |||
| TOTAL LIABILITIES AND EQUITY | 763.54M | 629.60M | 480.80M | 679.30M | 841.60M | |||
| Statistics | ||||||||
| Debt/Equity | -3.66 | -2.45 | -3.44 | 4.18 | 1.44 | |||
| Current Ratio | 1.17 | 1.43 | 2.75 | 3.64 | 5.27 | |||
| Return On Assets (ROA) | -7.76% | -37.78% | -60.69% | -42.26% | 15.71% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -293.86% | 47.05% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 17.74% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 79.82% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 81.66% | |||
All data in USD